Optopics Company Profile
✉ Email this page to a colleague
What is the competitive landscape for OPTOPICS
OPTOPICS has three approved drugs.
Drugs and US Patents for Optopics
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Optopics | PARACAINE | proparacaine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 087681-001 | Aug 5, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Optopics | SULFACEL-15 | sulfacetamide sodium | SOLUTION/DROPS;OPHTHALMIC | 080024-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Optopics | OPTOMYCIN | chloramphenicol | SOLUTION/DROPS;OPHTHALMIC | 062171-001 | Mar 31, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

